scholarly article | Q13442814 |
P356 | DOI | 10.1111/BJD.14864 |
P698 | PubMed publication ID | 27411503 |
P2093 | author name string | Y Kambayashi | |
T Fujimura | |||
T Hidaka | |||
S Aiba | |||
S Furudate | |||
A Kakizaki | |||
P2860 | cites work | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 |
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
Osteoclast differentiation and activation | Q29547556 | ||
Mammary and extramammary Paget's disease. | Q33924372 | ||
Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages | Q36118028 | ||
TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor | Q36380989 | ||
Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation | Q36765862 | ||
RANKL inhibition: a promising novel strategy for breast cancer treatment. | Q37865171 | ||
Targeting RANKL in breast cancer: bone metastasis and beyond | Q38081245 | ||
RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells | Q43505096 | ||
Clinicopathological study of invasive extramammary Paget's disease: subgroup comparison according to invasion depth | Q45376095 | ||
FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence. | Q53289573 | ||
Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages. | Q53475860 | ||
The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages. | Q54161562 | ||
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells | Q57184743 | ||
Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse | Q58211903 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 387-394 | |
P577 | publication date | 2016-07-14 | |
P1433 | published in | British Journal of Dermatology | Q4970191 |
P1476 | title | Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways. | |
P478 | volume | 176 |
Q61447969 | CD30-Positive Angioinvasive Lymphomatoid Papulosis (Type E) Developing from Parapsoriasis en Plaque |
Q47109271 | Langerhans Cells-Programmed by the Epidermis. |
Q52674779 | Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach. |
Q37634857 | Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab |
Search more.